Center for Cardiovascular and Pulmonary Research
Research Study: Genetic Testing of Individuals & Families with Congenital Heart Disease
Targeting Children with Single Ventricle from Before Birth Through Adulthood
The new LAUNCH program targets children with single ventricle heart defects from the womb through adulthood, providing care and collecting data at each phase of development.
Infliximab Reduces Fever Duration in Kawasaki Disease
Clinical trial finds that adding the antibody drug infliximab to standard treatment regimen decreases fever duration with Kawasaki disease.
New Anticoagulation Guidelines
The American Heart Association publishes the first evidence-based recommendations on anticoagulation in congenital heart disease.
Detecting Pediatric Cardiomyopathy
Early diagnosis and detection of familial or genetic risk of pediatric cardiomyopathy is key to treating and managing the disease.
Cardiac MRI Offers Valuable Tool
Program offers a 3-D view of cardiac defects and damage providing a roadmap for catheterization physicians and cardiothoracic surgeons.
Diagnosis and Treatment of Kawasaki Disease
A multidisciplinary effort to diagnose and treat Kawasaki disease is improving patient care at Nationwide Children’s.